Foster Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Foster Group's NVO Position: Q3 2025 in Review
Foster Group sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 3,554 shares — an estimated $245K sold.
Foster Group first reported a position in NVO in Q1 2024 and held it in 5 quarters. The position peaked at $310K in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.
- Foster Group reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
- Foster Group sold 3,554 Novo Nordisk shares in Q3 2025, an estimated $245K.
- Foster Group first reported a position in Novo Nordisk in Q1 2024 and held it in 5 quarters.
- Foster Group's Novo Nordisk position peaked at $310K in Q2 2024.
- 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.
Based on Foster Group's 13F filing for Q3 2025, filed 14 Oct 2025.